Trial Profile
Clinical Trials Insight: 700046601
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Jul 2009
Price :
$35
*
At a glance
- Drugs Elafibranor (Primary)
- Indications Glucose intolerance; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 09 Jul 2009 New trial record.